Related references
Note: Only part of the references are listed.Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation
G. J. BOLAND et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
David Andes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Empirical versus Preemptive Antifungal Therapy for High-Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial
Catherine Cordonnier et al.
CLINICAL INFECTIOUS DISEASES (2009)
Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety
Victor Monforte et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)
Antifungal management practices in liver transplant recipients
N. Singh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
When primary antifungal therapy fails
Marcio Nucci et al.
CLINICAL INFECTIOUS DISEASES (2008)
1,3-β-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia
Laurence Senn et al.
CLINICAL INFECTIOUS DISEASES (2008)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia:: A randomized, placebo-controlled trial
Bart J. Rijnders et al.
CLINICAL INFECTIOUS DISEASES (2008)
Risk factors for breakthrough invasive fungal infection during secondary prophylaxis
Oliver A. Cornely et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Empirical antifungal therapy in neutropaenic cancer patients with persistent fever
Oscar Marchetti et al.
EJC SUPPLEMENTS (2007)
Primary antifungal prophylaxis in leukaemia patients
Johan A. Maertens et al.
EJC SUPPLEMENTS (2007)
Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients
Raoul Herbrecht et al.
EJC SUPPLEMENTS (2007)
Immune reconstitution syndrome associated with opportunistic mycoses
Nina Singh et al.
LANCET INFECTIOUS DISEASES (2007)
Liposomal amphotericin B as initial therapy for invasive mold infection: A randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)
Oliver A. Cornely et al.
CLINICAL INFECTIOUS DISEASES (2007)
Multiple-triazole-resistant aspergillosis
Paul E. Verweij et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign
Reginald E. Greene et al.
CLINICAL INFECTIOUS DISEASES (2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease
Andrew J. Ullmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2007)
Invasive Aspergillosis - Epidemiology, diagnosis and management in immunocompromised patients
Georg Maschmeyer et al.
DRUGS (2007)
Voriconazole: a broad spectrum triazole for the treatment of serious and invasive fungal infections
Georg Maschmeyer et al.
FUTURE MICROBIOLOGY (2006)
Voriconazole prophylaxis in lung transplant recipients
S. Husain et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US:: Where will MELD lead us?
T. A. Gonwa et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Defining clinical failure for salvage studies
Georg Maschmeyer et al.
MEDICAL MYCOLOGY (2006)
Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients:: A 6-year survey
A. Cornillet et al.
CLINICAL INFECTIOUS DISEASES (2006)
Invasive aspergillosis in the recipients of liver retransplantation
Nina Singh et al.
LIVER TRANSPLANTATION (2006)
Antifungal prophylaxis in liver transplant patients: A systematic review and meta-analysis
Mario Cruciani et al.
LIVER TRANSPLANTATION (2006)
Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000
TE Zaoutis et al.
PEDIATRICS (2006)
Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases
JAH van Burik et al.
CLINICAL INFECTIOUS DISEASES (2006)
Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation
BD Alexander et al.
TRANSPLANT INFECTIOUS DISEASE (2006)
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients:: A prospective, multicenter, observational study
N Singh et al.
TRANSPLANTATION (2006)
An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia
A Glasmacher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
New antifungal agents under development in children and neonates
WJ Steinbach et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2005)
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: Impact of other therapies on outcome
TF Patterson et al.
CLINICAL INFECTIOUS DISEASES (2005)
Contamination of the nebulization systems used in the prophylaxis with amphotericin B nebulized in lung transplantation
V Monforte et al.
TRANSPLANTATION PROCEEDINGS (2005)
Galactomannan and computed tomography - Based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study
J Maertens et al.
CLINICAL INFECTIOUS DISEASES (2005)
Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer
G Chamilos et al.
CLINICAL INFECTIOUS DISEASES (2005)
Risk stratification and targeted antifungal prophylaxis for prevention of aspergillosis and other invasive mold infections after liver transplantation
WC Hellinger et al.
LIVER TRANSPLANTATION (2005)
Aspergillus infections in lung transplant recipients:: risk factors and outcome
A Solé et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli
MS Lionakis et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients
PH Chandrasekar et al.
CLINICAL INFECTIOUS DISEASES (2005)
Zygomycosis in a Tertiary-Care Cancer Center in the era of Aspergillus-active antifungal therapy:: A case-control observational study of 27 recent cases
DP Kontoyiannis et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections
JM Wiley et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Aspergillus infections in transplant recipients
N Singh et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Epidemiology and outcome of zygomycosis: A review of 929 reported cases
MM Roden et al.
CLINICAL INFECTIOUS DISEASES (2005)
Airway anastomosis complications in De Novo lung transplantation with sirolimus-based immunosuppression
J Groetzner et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2004)
Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients
C Cordonnier et al.
BONE MARROW TRANSPLANTATION (2004)
Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients
RH Drew et al.
TRANSPLANTATION (2004)
Aspergillus terreus - An emerging amphotericin B-resistant opportunistic mold in patients with Hematologic malignancies
RY Hachem et al.
CANCER (2004)
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
TJ Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Invasive aspergillosis in critically ill patients without malignancy
W Meersseman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole
A Imhof et al.
CLINICAL INFECTIOUS DISEASES (2004)
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy
J Maertens et al.
CLINICAL INFECTIOUS DISEASES (2004)
A survey of anti-fungal management in lung transplantation
JS Dummer et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2004)
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration
TJ Walsh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Epidemiology of Aspergillus terreus at a university hospital
JW Baddley et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Prevention of invasive fungal infections in liver transplant recipients:: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients
J Fortún et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Opportunistic mycelial fungal infections in organ transplant recipients:: Emerging importance of non-Aspergillus mycelial fungi
S Husain et al.
CLINICAL INFECTIOUS DISEASES (2003)
Aspergillus infections after lung transplantation:: Clinical differences in type of transplant and implications for management
N Singh et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2003)
Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients
N Singh et al.
CLINICAL INFECTIOUS DISEASES (2003)
Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole
AJ Ullmann
CURRENT MEDICAL RESEARCH AND OPINION (2003)
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
KA Marr et al.
BLOOD (2002)
Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies
H Hebart et al.
BLOOD (2002)
Risk factors for invasive aspergillosis in liver transplant recipients
J Fortún et al.
LIVER TRANSPLANTATION (2002)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Polymerase chain reaction detection of Aspergillus DNA in experimental models of invasive aspergillosis
J Loeffler et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
Invasive fungal infections after allogeneic peripheral blood stem cell transplantation:: incidence and risk factors in 395 patients
R Martino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
TJ Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The radiologic spectrum of pulmonary Aspergillus infections
MB Gotway et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2002)
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
TJ Walsh et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis
M Kami et al.
CLINICAL INFECTIOUS DISEASES (2001)
Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997
MM McNeil et al.
CLINICAL INFECTIOUS DISEASES (2001)
Safety of aerosolized amphotericin B lipid complex in lung transplant recipients
SM Palmer et al.
TRANSPLANTATION (2001)
Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction:: Clinical results
D Buchheidt et al.
CLINICAL INFECTIOUS DISEASES (2001)
Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation
J Maertens et al.
BLOOD (2001)
Aspergillosis case - Fatality rate: Systematic review of the literature
SJ Lin et al.
CLINICAL INFECTIOUS DISEASES (2001)
Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients
R Herbrecht et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2001)
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans
KA Marr et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years
L Hovi et al.
BONE MARROW TRANSPLANTATION (2000)
Invasive mycoses in organ transplant recipients: controversies in prophylaxis and management
N Singh
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Share Paper
